Sociological influences on antidepressant prescribing

Social Science and Medicine

Volumn 56, Issue 6, 2003, Pages 1335-1344

  Sleath, Betsy ^a   Shih, Ya Chen Tina ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Antidepressant; Depression; Insurance status; Prescribing; Sociological influences; USA

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

DRUG PRESCRIBING; HEALTH CARE; MENTAL HEALTH;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; SOCIAL ASPECT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; PSYCHIATRY; SEROTONIN UPTAKE INHIBITORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 0037367144     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(02)00132-6     Document Type: Article

References (34)

1. Aparasu R.R., Mort J.R., Sitzman S. Psychotropic prescribing for the elderly in office-based practice. Clinical Therapeutic. 20:1998;603-616.
2. Bartels S.J., Horn S., Sharkey P., Levine K. Treatment of depression in older primary care patients in health maintenance organizations. International Journal of Psychiatric Medicine. 27:1997;215-231.
3. Blustein, J. (2000). Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Affairs, 219-230.
4. Bradley C.P. Decision-making and prescribing patterns - a literature review. Family Practice. 8(3):1991;276-287.
5. Butler R., Collins E., Katona C., Orrell M. How do general practitioners select antidepressants for depressed elderly people? International Journal of Geriatric Psychiatry. 15:2000;610-613.
6. Clark J.A., Potter D.A., McKinlary J.B. Bringing social structure back into clinical decision making. Social Science & Medicine. 32(8):1991;853-866.
7. Denig P., Haaijer-Ruskamp F.M., Zijsling D.H. How physicians choose drugs. Social Science & Medicine. 27(12):1988;1381-1386.
8. Eisenberg J. Sociologic influences on decision-making by clinicians. Annals of Internal Medicine. 90:1979;957-964.
9. Frank L., Revicki D., Sorensen S.V., Shih Y. The economics of selective serotonin reuptake inhibitors in depression. A critical review CNS Drugs. 15(1):2001;59-83.
10. Gabe J. Towards a sociology of tranquilizer prescribing. British Journal of Addiction. 85:1990;41-48.
11. Ganguli M., Mulsant B., Richards S., Stoehr G., Mendelsohn A. Antidepressant use over time in a rural older adult population. The MOVIES project Journal of the American Geriatric Society. 45:1997;1501-1503.
12. Green-Hennessy S., Hennessy K. Demographic differences in medication use among individuals with self-reported major depression. Psychiatric Services. 50(2):1999;257-259.
13. Greene, W. H. (1997). Limited dependent variable and duration models. In: Economteric Analysis (3rd Ed.). Upper Saddle River, NJ: Prentice-Hall Inc. (Chap. 20).
14. Heckman J. The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Annals of Economic and Social Measurement. 5:1976;475-492.
15. Hohmann A. Gender bias in psychotropic drug prescribing in primary care. Medical Care. 27:1989;478-490.
16. Lee E.S., Forthofer R.N., Lorimor R.J. Analysis of complex sample survey data. Problems and strategies Sociological Methods and Research. 15:1986;69-100.
17. Leugn S.F., Yu S. On the choice between sample selection and two-part models. Journal of Econometrics. 72:1996;197-229.
18. Lilja J. How physicians choose their drugs. Social Science & Medicine. 10:1976;363-365.
19. Maddala G.S. Limited-dependent and qualitative variables in econometrics. 1983;Cambridge University Press, Cambridge.
20. Martin R.M., Hilton S.R., Kerry S.M., Richards N.M. General practitioners' perceptions of the tolerability of antidepressant drugs. A comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants British Medical Journal. 314:1997;646-651.
21. Mason J., Freemantle N., Eccles M. Fatal toxicity associated with antidepressant use in primary are. British Journal of General Practitioners. 50:2000;366-370.
22. Melfi C., Croghan T., Hanna M.P., Robinson R.L. Racial variation in antidepressant treatment in a medicaid population. Journal of Clinical Psychiatry. 61(1):2000;16-21.
23. Nelson J.C.N. Safety and tolerability of the new antidepressants. Journal of Clinical Psychiatry. 58(Suppl. 6):1997;26-31.
24. Olfson M., Klerman G.L. The treatment of depression. Prescribing practices of primary care physicians and psychiatrists Journal of Family Practice. 35:1992;627-635.
25. Pincus H.A., Tanielian T.L., Marcus S.C., Olfson M., Zarin D.A., Thompson J., Zito J.M. Prescribing trends in psychotropic medications. Journal of American Medical Association. 279:1998;526-531.
26. Poisal, J., & Chulis, G. (2000). Medicare beneficiaries and drug coverage. Health Affairs, 248-256.
27. Reichert S., Simon T., Halm E. Physicians' attitudes about prescribing and knowledge about the cost of common medications. Archives of Internal Medicine. 160:2000;2799-2803.
28. Samuelson, R. J. (1999). Myths of the uninsured. Newsweek, 73.
29. Simon G.E., VonKorff M., Heiligenstein J.H., Revicki D.A., Grothaus L., Waton W., Wagner E.H. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine versus tricyclic antidepressants Journal of the American Medical Association. 275(24):1996;1897-1902.
30. Simoni-Wastila L. Gender and psychotropic drug use. Medical Care. 36(1):1998;88-94.
31. Wells K.B., Katon W., Rogers B., Camp P. Use of minor tranquilizers and antidepressant medications by depressed outpatients. Results from the medical outcomes study American Journal of Psychiatry. 151(5):1994;694-700.
32. Willams J., Mulrow C., Chiquette E., Noel P., Aguilar C., Cornell J. A systematic review of newer pharmacotherapies for depression in adults. Evidence report summary Annals of Internal Medicine. 132(9):2000;743-756.
33. Woodwell, D. A. (2000). National ambulatory medical care survey: 1998 summary. Advance data from vital and health statistics: no. 315. Hyattsville, Maryland: National Center for Health Statistics.
34. Wooldridge, J. M. (2000). Chapter 17 in introductory econometrics - a modern approach. South-Western College Publishing. Thomson Learning.